Reeth Mark D 4
4 · SALIX PHARMACEUTICALS LTD · Filed May 3, 2012
Insider Transaction Report
Form 4
Reeth Mark D
Gen Counsel&VP Corp Compliance
Transactions
- Sale
Common Stock
2012-05-01$48.91/sh−1,000$48,910→ 33,668 total
Footnotes (2)
- [F1]The shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 11, 2011.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $48.86 to $48.94, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4.